Stock Comparison

ELAN vs TEVA

Elanco Animal Health and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.

ELAN

Elanco Animal Health

Healthcare

TEVA

Teva Pharma Industries Ltd ADR

Healthcare

Valuation

Market Cap

$11.15B

$41.60B

P/E (TTM)

—

59.5

Forward P/E

20.3

17.2

Price/Sales

2.2

2.4

Price/Book

1.7

5.4

EV/EBITDA

18.7

20.9

Dividend Yield

—

Profitability

Net Margin

-4.95%

9.02%

Operating Margin

8.95%

13.19%

Return on Equity

-2.98%

9.69%

Return on Assets

1.56%

5.13%

Growth (YoY)

Revenue Growth

10.20%

-0.80%

Earnings Growth

440.50%

72.20%

Price & Risk

Beta

1.7

0.9

52-Week High

$26.84

$36.74

52-Week Low

$17.35

$17.54

Analyst Target

$31.21

$41.20

Compare ELAN and TEVA your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.